In a nutshell This study investigated the cardiovascular effects of chemotherapy after colorectal cancer (CRC) surgery. Researchers suggested that this treatment increases the stiffness of blood vessels in patients with CRC. Some background Colorectal cancer is a major cause of cancer mortality. However, the mortality rate has decreased in the...
Read MoreCurrent stage-Stage II Posts on Medivizor
Adjuvant chemotherapy improves survival of patients with locally advanced rectal cancer
In a nutshell This study investigated the role and optimal dose and duration of adjuvant (after surgery) chemotherapy (AC) in patients with locally advanced rectal cancer. Researchers suggested that this treatment was associated with improved survival in these patients. Some background Colorectal cancer is one of the most common cancers worldwide....
Read MoreBenefits of therapy for early stage breast cancer
In a nutshell This paper is a document that was developed at a breast cancer conference by a number of experts in the field. It outlines suggested treatment for early-stage breast cancer. The experts concluded that patients and doctors should work together and discuss the benefit of treating early-stage breast cancer in comparison with the potential...
Read MoreAre abdominal infections a prognostic factor for recurrence after colorectal cancer surgery?
In a nutshell This study investigated whether tummy infections (TIs) after surgery are associated with colorectal cancer outcomes. Researchers suggested that TIs might be associated with a shorter time until recurrence. Some background Colorectal cancer is a common cancer in the US affecting more than 145,000 people every year. Surgery is...
Read MoreComparing 6- and 12-month trastuzumab treatment after surgery for early breast cancer
In a nutshell This study aimed to compare the outcomes for patients with early breast cancer who received 6- or 12-months trastuzumab after surgery. This study concluded that the standard duration of trastuzumab after surgery should remain 12 months. Some background Trastuzumab (Herceptin) is a targeted...
Read MoreSurgery followed by chemotherapy improves the outcomes of patients with rectal cancer
In a nutshell This study investigated the effectiveness of surgery followed by chemotherapy without chemoradiotherapy (CRT) before surgery to treat rectal cancer. Researchers suggested that this treatment improves the outcomes of these patients. Some background Colorectal cancer is the third most common cancer worldwide. The standard...
Read MoreComparing letrozole and taselisib against letrozole and placebo before surgery in early stage breast cancer
In a nutshell This study aimed to investigate the combination of letrozole and taselisib as a neoadjuvant treatment (before surgery) in patients with hormone receptor-positive, HER2-negative, early stage breast cancer. This study concluded that this treatment...
Read MoreTalazoparib before surgery for patients with BRCA mutated breast cancer
In a nutshell This study aimed to investigate the effectiveness and safety of talazoparib as a neoadjuvant agent (treatment before surgery) in patients with BRCA mutation and operable breast cancer. This study concluded that this treatment was a safe and effective in these patients. Some...
Read MoreIs there a best duration of post-surgery chemotherapy in patients with colon cancer?
In a nutshell This study compared a 3-month with a 6-month chemotherapy treatment after colon cancer surgery. Researchers suggested that the duration of the treatment should be chosen according to the patient condition. Some background Colorectal cancer is one of the most common cancers worldwide. Stage 2 and 3 colon cancer are common and curable...
Read MoreSearching for patients with breast cancer to test an anti-fatigue treatment.
In a nutshell This phase 3 trial will investigate the effect of bupropion (Wellbutrin) to treat fatigue in patients with breast cancer (BC). The main outcomes will be fatigue, quality of life and depression. This trial is recruiting across the United States. The details After treatment for breast cancer (BC), many women report feeling...
Read MoreTrastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer
In a nutshell This study wanted to find out which treatment was better before surgery for patients with HER2-positive breast cancer, trastuzumab emtansine (Kadcycla) plus pertuzumab (Perjeta), or a standard treatment. The study found that patients treated with trastuzumab emtansine plus pertuzumab (TEP) were more likely to have cancer...
Read MoreRadiation vs. thermal – a comparison of strategies for the treatment of early lung cancer
In a nutshell This study compared stereotactic body radiation therapy (SBRT) and thermal ablative procedures (TAP) in early-stage non-small cell lung cancer (NSCLC). They found that overall survival (OS) was greater in SBRT-treated patients. Some background Non-small cell lung cancer (NSCLC) is the most common form of lung...
Read More
